Axonis Therapeutics Announces $115 Million Series A Financing
Provided By PR Newswire
Last update: Oct 30, 2024
-- Oversubscribed financing brings together leading syndicate of life sciences investors --
-- Proceeds to support clinical development of first-in-class therapies for neurological disorders –
Read more at prnewswire.com51.84
+1.26 (+2.49%)
27.52
-0.83 (-2.93%)
NASDAQ:PHVS (2/21/2025, 8:00:01 PM)
16.49
-0.01 (-0.06%)
7.93
+0.1 (+1.28%)
34.56
-0.33 (-0.95%)
Find more stocks in the Stock Screener
